James J. Pai

James J. Pai

Auto-generated profile, based on publicly available information

James J. Pai

Arc Institute, Palo Alto, USA

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 June 2024 in Nature
Verified
Journal Article
Open access
PDF file
MDMatthew G. Durrant
Matthew G. Durrant
NPNicholas T. Perry
Nicholas T. Perry
JPJames J. Pai
James J. Pai
AJAditya R. Jangid
Aditya R. Jangid
JAJanuka S. Athukoralage
Januka S. Athukoralage
PHPatrick D. Hsu
Patrick D. Hsu
Genomic rearrangements, encompassing mutational changes in the genome such as insertions, deletions or inversions, are essential for genetic diversity. These rearrangements are typically orchestrated by enzymes that are involved in fundamental DNA repair processes, such as homologous recombination, or in the transposition of foreign genetic material by viruses and mobile genetic elements1,2. Here we report that IS110 insertion sequences, a family of minimal and autonomous mobile genetic elements, express a structured non-coding RNA that binds specifically to their encoded recombinase. This bridge RNA contains two internal loops encoding nucleotide stretches that base-pair with the target DNA and the donor DNA, which is the IS110 element itself. We demonstrate that the target-binding and donor-binding loops can be independently reprogrammed to direct sequence-specific recombination between two DNA molecules. This modularity enables the insertion of DNA into genomic target sites, as well as programmable DNA excision and inversion. The IS110 bridge recombination system expands the diversity of nucleic-acid-guided systems beyond CRISPR and RNA interference, offering a unified mechanism for the three fundamental DNA rearrangements—insertion, excision and inversion—that are required for genome design.

26 June 2024 in Nature
Verified
Journal Article
Open access
PDF file
MHMasahiro Hiraizumi
Masahiro Hiraizumi
NPNicholas T. Perry
Nicholas T. Perry
MDMatthew G. Durrant
Matthew G. Durrant
TSTeppei Soma
Teppei Soma
NNNaoto Nagahata
Naoto Nagahata
HNHiroshi Nishimasu
Hiroshi Nishimasu
Insertion sequence (IS) elements are the simplest autonomous transposable elements found in prokaryotic genomes1. We recently discovered that IS110 family elements encode a recombinase and a non-coding bridge RNA (bRNA) that confers modular specificity for target DNA and donor DNA through two programmable loops2. Here we report the cryo-electron microscopy structures of the IS110 recombinase in complex with its bRNA, target DNA and donor DNA in three different stages of the recombination reaction cycle. The IS110 synaptic complex comprises two recombinase dimers, one of which houses the target-binding loop of the bRNA and binds to target DNA, whereas the other coordinates the bRNA donor-binding loop and donor DNA. We uncovered the formation of a composite RuvC–Tnp active site that spans the two dimers, positioning the catalytic serine residues adjacent to the recombination sites in both target and donor DNA. A comparison of the three structures revealed that (1) the top strands of target and donor DNA are cleaved at the composite active sites to form covalent 5′-phosphoserine intermediates, (2) the cleaved DNA strands are exchanged and religated to create a Holliday junction intermediate, and (3) this intermediate is subsequently resolved by cleavage of the bottom strands. Overall, this study reveals the mechanism by which a bispecific RNA confers target and donor DNA specificity to IS110 recombinases for programmable DNA recombination.

25 June 2024 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
RAReema A. Apte
Reema A. Apte
ASAndrea L. Smidler
Andrea L. Smidler
JPJames J. Pai
James J. Pai
MCMartha L. Chow
Martha L. Chow
SCSanle Chen
Sanle Chen
OAOmar Akbari
Omar Akbari
Controlling the principal African malaria vector, the mosquito Anopheles gambiae , is considered essential to curtail malaria transmission. However, existing vector control technologies rely on insecticides, which are becoming increasingly ineffective. Sterile insect technique (SIT) is a powerful suppression approach that has successfully eradicated a number of insect pests, yet the A. gambiae toolkit lacks the requisite technologies for its implementation. SIT relies on iterative mass releases of nonbiting, nondriving, sterile males which seek out and mate with monandrous wild females. Once mated, females are permanently sterilized due to mating-induced refractoriness, which results in population suppression of the subsequent generation. However, sterilization by traditional methods renders males unfit, making the creation of precise genetic sterilization methods imperative. Here, we introduce a vector control technology termed precision-guided sterile insect technique (pgSIT), in A. gambiae for inducible, programmed male sterilization and female elimination for wide-scale use in SIT campaigns. Using a binary CRISPR strategy, we cross separate engineered Cas9 and gRNA strains to disrupt male-fertility and female-essential genes, yielding >99.5% male sterility and >99.9% female lethality in hybrid progeny. We demonstrate that these genetically sterilized males have good longevity, are able to induce sustained population suppression in cage trials, and are predicted to eliminate wild A. gambiae populations using mathematical models, making them ideal candidates for release. This work provides a valuable addition to the malaria genetic biocontrol toolkit, enabling scalable SIT-like confinable, species-specific, and safe suppression in the species.

7 July 2023 in Science Advances
Verified
Journal Article
Open access
ASAndrea L. Smidler
Andrea L. Smidler
JPJames J. Pai
James J. Pai
RAReema A. Apte
Reema A. Apte
HCHector Manuel Sanchez Castellanos
Hector Manuel Sanchez Castellanos
RCRodrigo M. Corder
Rodrigo M. Corder
OAOmar Akbari
Omar Akbari
Malaria is among the world’s deadliest diseases, predominantly affecting Sub-Saharan Africa and killing over half a million people annually. Controlling the principal vector, the mosquito Anopheles gambiae , as well as other anophelines, is among the most effective methods to control disease spread. Here, we develop a genetic population suppression system termed Ifegenia (inherited female elimination by genetically encoded nucleases to interrupt alleles) in this deadly vector. In this bicomponent CRISPR-based approach, we disrupt a female-essential gene, femaleless ( fle ), demonstrating complete genetic sexing via heritable daughter gynecide. Moreover, we demonstrate that Ifegenia males remain reproductively viable and can load both fle mutations and CRISPR machinery to induce fle mutations in subsequent generations, resulting in sustained population suppression. Through modeling, we demonstrate that iterative releases of nonbiting Ifegenia males can act as an effective, confinable, controllable, and safe population suppression and elimination system.

12 March 2026 in Science
Verified
Journal Article
Closed access
NPNicholas T. Perry
Nicholas T. Perry
LBLiam J. Bartie
Liam J. Bartie
DKDhruva Katrekar
Dhruva Katrekar
GGGabriel A. Gonzalez
Gabriel A. Gonzalez
MDMatthew G. Durrant
Matthew G. Durrant
PHPatrick D. Hsu
Patrick D. Hsu
Bridge recombinases are naturally occurring RNA-guided DNA recombinases that we previously demonstrated can programmably insert, excise, and invert DNA in vitro and in Escherichia coli . In this study, we report the discovery and engineering of the bridge recombinase ortholog ISCro4 for universal rearrangements of the human genome. We defined strategies for the optimal application of bridge systems, leveraging mechanistic insights to improve their targeting specificity. Through rational engineering of the ISCro4 bridge RNA and deep mutational scanning of its recombinase, we achieved up to 20% insertion efficiency into the human genome and genome-wide specificity as high as 82%. We further demonstrated intrachromosomal inversion and excision, mobilizing up to 0.93 megabases of DNA. Lastly, we provided proof of concept for plasmid-based excision of disease-relevant gene regulatory regions or repeat expansions.

14 May 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
NPNicholas T. Perry
Nicholas T. Perry
LBLiam J. Bartie
Liam J. Bartie
DKDhruva Katrekar
Dhruva Katrekar
GGGabriel A. Gonzalez
Gabriel A. Gonzalez
MDMatthew G. Durrant
Matthew G. Durrant
PHPatrick D. Hsu
Patrick D. Hsu
Bridge recombinases are a class of naturally occurring RNA-guided DNA recombinases. We previously demonstrated they can programmably insert, excise, and invert DNA in vitro and in bacteria. Here, we report the discovery and engineering of IS622, a simple two-component system capable of universal DNA rearrangements of the human genome. We define strategies for the optimal application of bridge systems, leveraging mechanistic insights to improve their targeting specificity. Through rational engineering of the IS622 bridge RNA and deep mutational scanning of its recombinase, we achieve up to 20% insertion efficiency into the human genome and genome-wide specificity as high as 82%. We further demonstrate intra-chromosomal inversion and excision, mobilizing up to 0.93 megabases of DNA. Finally, we provide proof-of concept for excision of a gene regulatory region or expanded repeats relevant for the treatment of genetic diseases.